Cargando…
Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation
BACKGROUND: An international randomized clinical trial (RCT) on pre-exposure prophylaxis (PrEP) as an human immunodeficiency virus (HIV)-prevention intervention found that taken on a daily basis, PrEP was safe and effective among men who have sex with men (MSM) and male-to-female transgender women....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527231/ https://www.ncbi.nlm.nih.gov/pubmed/23181780 http://dx.doi.org/10.1186/1748-5908-7-116 |
_version_ | 1782253680276275200 |
---|---|
author | Galindo, Gabriel R. Garrett-Walker, J. J. Hazelton, Patrick Lane, Tim Steward, Wayne T. Morin, Stephen F. Arnold, Emily A. |
author_facet | Galindo, Gabriel R. Garrett-Walker, J. J. Hazelton, Patrick Lane, Tim Steward, Wayne T. Morin, Stephen F. Arnold, Emily A. |
author_sort | Galindo, Gabriel R. |
collection | PubMed |
description | BACKGROUND: An international randomized clinical trial (RCT) on pre-exposure prophylaxis (PrEP) as an human immunodeficiency virus (HIV)-prevention intervention found that taken on a daily basis, PrEP was safe and effective among men who have sex with men (MSM) and male-to-female transgender women. Within the context of the HIV epidemic in the United States (US), MSM and transgender women are the most appropriate groups to target for PrEP implementation at the population level; however, their perspectives on evidenced-based biomedical research and the results of this large trial remain virtually unknown. In this study, we examined the acceptability of individual daily use of PrEP and assessed potential barriers to community uptake. METHODS: We conducted semi-structured interviews with an ethnoracially diverse sample of thirty HIV-negative and unknown status MSM (n = 24) and transgender women (n = 6) in three California metropolitan areas. Given the burden of disease among ethnoracial minorities in the US, we purposefully oversampled for these groups. Thematic coding and analysis of data was conducted utilizing an approach rooted in grounded theory. RESULTS: While participants expressed general interest in PrEP availability, results demonstrate: a lack of community awareness and confusion about PrEP; reservations about PrEP utilization, even when informed of efficacious RCT results; and concerns regarding equity and the manner in which a PrEP intervention could be packaged and marketed in their communities. CONCLUSIONS: In order to effectively reduce HIV health disparities at the population level, PrEP implementation must take into account the uptake concerns of those groups who would actually access and use this biomedical intervention as a prevention strategy. Recommendations addressing these concerns are provided. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1748-5908-7-116) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-3527231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35272312012-12-21 Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation Galindo, Gabriel R. Garrett-Walker, J. J. Hazelton, Patrick Lane, Tim Steward, Wayne T. Morin, Stephen F. Arnold, Emily A. Implement Sci Research BACKGROUND: An international randomized clinical trial (RCT) on pre-exposure prophylaxis (PrEP) as an human immunodeficiency virus (HIV)-prevention intervention found that taken on a daily basis, PrEP was safe and effective among men who have sex with men (MSM) and male-to-female transgender women. Within the context of the HIV epidemic in the United States (US), MSM and transgender women are the most appropriate groups to target for PrEP implementation at the population level; however, their perspectives on evidenced-based biomedical research and the results of this large trial remain virtually unknown. In this study, we examined the acceptability of individual daily use of PrEP and assessed potential barriers to community uptake. METHODS: We conducted semi-structured interviews with an ethnoracially diverse sample of thirty HIV-negative and unknown status MSM (n = 24) and transgender women (n = 6) in three California metropolitan areas. Given the burden of disease among ethnoracial minorities in the US, we purposefully oversampled for these groups. Thematic coding and analysis of data was conducted utilizing an approach rooted in grounded theory. RESULTS: While participants expressed general interest in PrEP availability, results demonstrate: a lack of community awareness and confusion about PrEP; reservations about PrEP utilization, even when informed of efficacious RCT results; and concerns regarding equity and the manner in which a PrEP intervention could be packaged and marketed in their communities. CONCLUSIONS: In order to effectively reduce HIV health disparities at the population level, PrEP implementation must take into account the uptake concerns of those groups who would actually access and use this biomedical intervention as a prevention strategy. Recommendations addressing these concerns are provided. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1748-5908-7-116) contains supplementary material, which is available to authorized users. BioMed Central 2012-11-26 /pmc/articles/PMC3527231/ /pubmed/23181780 http://dx.doi.org/10.1186/1748-5908-7-116 Text en © Galindo et al.; licensee BioMed Central Ltd. 2012 https://creativecommons.org/licenses/by/2.0/This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0 (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Galindo, Gabriel R. Garrett-Walker, J. J. Hazelton, Patrick Lane, Tim Steward, Wayne T. Morin, Stephen F. Arnold, Emily A. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation |
title | Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation |
title_full | Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation |
title_fullStr | Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation |
title_full_unstemmed | Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation |
title_short | Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation |
title_sort | community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an hiv prevention strategy: implications for implementation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527231/ https://www.ncbi.nlm.nih.gov/pubmed/23181780 http://dx.doi.org/10.1186/1748-5908-7-116 |
work_keys_str_mv | AT galindogabrielr communitymemberperspectivesfromtransgenderwomenandmenwhohavesexwithmenonpreexposureprophylaxisasanhivpreventionstrategyimplicationsforimplementation AT garrettwalkerjj communitymemberperspectivesfromtransgenderwomenandmenwhohavesexwithmenonpreexposureprophylaxisasanhivpreventionstrategyimplicationsforimplementation AT hazeltonpatrick communitymemberperspectivesfromtransgenderwomenandmenwhohavesexwithmenonpreexposureprophylaxisasanhivpreventionstrategyimplicationsforimplementation AT lanetim communitymemberperspectivesfromtransgenderwomenandmenwhohavesexwithmenonpreexposureprophylaxisasanhivpreventionstrategyimplicationsforimplementation AT stewardwaynet communitymemberperspectivesfromtransgenderwomenandmenwhohavesexwithmenonpreexposureprophylaxisasanhivpreventionstrategyimplicationsforimplementation AT morinstephenf communitymemberperspectivesfromtransgenderwomenandmenwhohavesexwithmenonpreexposureprophylaxisasanhivpreventionstrategyimplicationsforimplementation AT arnoldemilya communitymemberperspectivesfromtransgenderwomenandmenwhohavesexwithmenonpreexposureprophylaxisasanhivpreventionstrategyimplicationsforimplementation |